Research funders need to take action to ensure that discoveries progress from the lab to the world. They are uniquely placed to develop and promote collaborations between multiple partners, including industry, in a positive and ethical way.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wouters, O. J., McKee, M. & Luyten, J. Estimated research and development investment needed to bring a new medicine to market, 2009-2018. JAMA. 323, 844–853 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors are employees of Cancer Research UK.
Additional information
Related links
CRUK Centre for Drug Development: https://www.cancerresearchuk.org/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development
CRUK Entrepreneurial Programme: https://www.cancerresearchuk.org/funding-for-researchers/translate-your-research/entrepreneurial-programmes
CRUK Therapeutic Discovery Laboratories: http://discoverylabs.cancerresearchuk.org/
LifeArc: https://www.lifearc.org/
Rights and permissions
About this article
Cite this article
Tzircotis, G., Hickson, T. & Foulkes, I. Funding bodies should foster partnerships between industry and academia. Nat Rev Cancer 21, 65–66 (2021). https://doi.org/10.1038/s41568-020-00326-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-020-00326-w
